VIDEO: Baricitinib approval ‘major breakthrough’ for alopecia areata

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

So the big news is that baricitinib, which is a JAK inhibitor, was recently a FDA approved for alopecia areata, and this is a major breakthrough for this disease. It has really changed our practice now having something that is actually FDA-approved.